Длительная биотерапия трастузумабом больной раком молочной железы
L. N. Volodina, Evgeniy Petrovich Kulikov, Андрей Григорьев et al. · Russian Journal of Oncology · 2015
The paper describes a clinical case of long-term Trastuzumab biotherapy of a patient with HER2-positive breast cancer. The patient with morphology confirmed HER2+ breast cancer has received Trastuzumab therapy over 9 years. CT data proved complete resorption of metastases in the lungs. No adverse events, which could limit trastuzumab treatment, were noted. The clinical case illustrates effective long-term Trastuzumab therapy of a patient with metastatic HER2+ breast cancer.
Cited by 0 works.